Skip to content

Therapeutic community intervention trial

An exploratory randomised trial of day-therapeutic community treatment for people with personality disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN57363317
Enrollment
85
Registered
2010-02-18
Start date
2009-07-01
Completion date
Unknown
Last updated
2022-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Personality disorder Mental and Behavioural Disorders Specific personality disorders

Interventions

Democratic Therapeutic Communities (DTC) is a form of psychosocial treatment based on a collaborative and deinstitutionalised approach to staff-patient interaction
particular emphasis is placed on personal responsibility, sharing and participation in communal activity. The four day Democratic Therapeutic Communities taking part in this study are
these elements will be delivered by local general practitioners or Community Mental Health Teams.

Sponsors

Oxfordshire and Buckinghamshire Mental Health NHS Foundation Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The study sample will be recruited from people in contact with primary care or mental health services and living in Oxfordshire. Day-Therapeutic Community services in this area are provided at four communities (in Oxford, Banbury, Wallingford and Witney). The study sample will be: 1. Resident in the community 2. Aged between 16 and 65 3. Have a diagnosis of personality disorder (assessed using the Structured Clinical Interview (II) for Axis 2 disorder)

Exclusion criteria

Exclusion criteria: 1. A primary diagnosis of a psychotic disorder, alcohol or drug dependence (those with a history of transient psychotic symptoms and non-dependent substance misuse will be included) 2. A degree of learning disability, or intellectual impairment which prevents engagement in Therapeutic Community services 3. Unwilling to provide written informed consent to participate in the trial

Design outcomes

Primary

MeasureTime frame
Number of days of inpatient psychiatric treatment in the year following randomisation.

Secondary

MeasureTime frame
1. Mental health - assessed using the General Health Questionnaire 2. Social Functioning - assessed using the Social Function Questionnaire 3. Extent of any aggressive behaviour towards others using the Modified Overt Aggression Scale 4. Satisfaction with care using the 8-item Client Satisfaction Questionnaire 5. Quality of life using Euro-Qol 6. Frequency of suicidal acts and acts of deliberate self harm collected via a self-report questionnaire developed specifically for the study 7. Direct costs (healthcare and non-health care) and productivity costs using a self-report questionnaire developed specifically for the study 8. Symptoms of personality disorder, and whether participants continue to fulfil criteria, will be assessed by repeat administration of the Structured Clinical Interview for DSM IV Axis II Personality Disorders.

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 11, 2026